Aemetis, inc. (AMTX)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Operating activities:
Net loss

-40,862

-39,477

-44,134

-43,557

-35,849

-36,287

-33,015

-34,583

-34,348

-31,770

-24,176

-20,054

-19,050

-15,636

-20,644

-22,304

-23,608

-27,138

-24,425

-18,206

-9,197

7,133

14,131

5,378

-6,936

-24,437

-34,532

-5,575

-5,731

-4,282

341

-25,776

-22,397

-18,296

0

0

0

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Share-based compensation

794

774

828

886

1,007

981

1,084

1,078

956

1,101

974

950

1,039

747

817

806

902

938

871

867

646

624

622

1,370

1,598

1,760

1,785

1,087

908

686

441

350

194

177

0

0

0

Stock issued for services

-

-

-

-

-

22

140

140

140

118

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation

4,386

4,434

4,460

4,515

4,568

4,580

4,608

4,623

4,626

4,622

4,618

4,615

4,641

4,670

4,693

4,695

4,710

4,730

4,755

4,767

4,724

4,681

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

2,231

1,360

1,296

1,141

0

0

0

Debt related fees and amortization expense

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

4,437

4,624

0

0

0

Intangibles and other amortization expense

48

48

71

94

117

140

399

398

394

392

129

127

127

126

128

128

129

129

127

126

126

126

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of Series A preferred units

2,768

2,257

1,553

964

493

44

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

-

-

-

-

Loss on sale/disposal of assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Deferred tax benefit

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangibles and other amortization expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

Gain on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-330

-330

-1,561

-1,561

-1,346

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of stock appreciation rights

-115

-80

-181

-85

-110

-145

-47

-3

-5

0

-56

-34

-36

-25

37

-1

-9

-54

-111

-112

-29

48

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Gain on sale of assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-188

-200

439

401

0

0

0

Changes in operating assets and liabilities:
Accounts receivable

-394

963

3,950

2,208

135

-1,079

-587

774

1,343

1,015

1,485

537

44

403

-1,210

-1,432

-667

-72

1,820

1,336

-645

-1,498

-1,547

-3,863

319

1,487

-5,017

400

-1,815

-3,114

1,993

158

-1,818

-1,316

0

0

0

Inventories

-757

491

-4,430

-2,585

144

721

2,502

929

3,618

2,370

1,747

2,883

1

-1,504

305

-2,195

-1,670

450

-1,305

555

624

457

226

781

-443

-211

1,582

-159

13

740

545

-563

-2,337

-3,724

0

0

0

Prepaid expenses

343

-147

-525

-990

-1,401

-1,692

-1,833

-1,745

-1,177

-371

21

467

170

28

-493

-796

-619

-1,109

45

-237

-197

311

-297

145

-198

-14

-476

-402

40

-148

108

-82

-41

-172

0

0

0

Other assets

-54

594

190

-315

223

380

728

460

803

425

-1,024

-2,415

-1,469

-890

1,105

2,505

1,576

979

-105

-111

-231

187

0

0

0

-

-

-

-

-

-

-

-

-

-

-

0

Accounts payable

-680

1,001

2,637

2,783

3,663

2,207

4,072

3,568

4,182

2,580

725

2,184

-452

-2,097

1,186

-1,043

-488

2,020

-1,052

-777

1,134

-879

0

0

0

-

-

-

-

-

-

-

-

-

-

-

0

Accrued interest expense and fees

19,272

18,033

17,284

15,307

13,767

12,463

11,172

11,443

11,732

10,812

8,629

6,031

5,478

6,448

8,264

10,244

10,326

9,800

9,903

7,551

5,400

3,124

0

0

0

-

-

-

-

-

-

-

-

-

-

-

0

Other liabilities

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Other current assets and other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

-

-

-

-

Accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

-

-

-

-

Accrued interest expense and fees, net of payments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

-

-

-

-

Other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

-

-

-

-

Other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net cash provided by (used in) operating activities

683

-2,034

-3,278

-5,132

-7,586

-5,506

-5,686

-5,449

-6,245

-8,688

-6,429

-3,566

-2,816

371

2,470

1,836

1,619

-786

-4,230

-2,224

7,650

20,592

26,413

23,391

13,527

-1,683

-10,538

-17,738

-17,936

-16,931

-11,668

-5,021

-4,256

-1,246

0

0

0

Investing activities:
Capital expenditures

10,352

8,578

6,629

3,341

3,676

4,074

2,933

2,376

2,068

1,116

831

740

365

629

528

456

365

71

153

1,513

1,732

1,965

2,681

1,668

1,494

1,276

507

775

1,364

1,368

1,339

1,195

891

2,568

0

0

0

Proceeds from the sale of assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Proceeds from sale of land

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

Net cash used in investing activities

-10,352

-8,578

-6,629

-3,341

-3,676

-4,074

-2,933

-2,376

-2,068

-1,116

-831

-740

-365

-629

-528

-456

-365

-71

-252

-1,612

-1,732

-1,965

-2,257

-469

-394

224

950

-16,593

-16,060

-16,464

-16,718

-71

708

-967

0

0

0

Financing activities:
Proceeds from borrowings

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

51,732

51,617

47,165

0

0

0

-

-

-

-

Repayments of borrowings

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15,541

14,889

13,830

0

0

0

-

-

-

-

Proceeds from borrowings

-

-

-

-

-

-

-

-

-

14,798

25,194

27,410

22,849

20,583

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from borrowings

-2,089

1,480

24,863

6,445

5,289

3,144

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of borrowings

-1,950

164

25,048

7,295

3,312

1,775

3,560

1,792

2,172

0

19,754

23,235

19,863

18,956

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from borrowings under unsecured and subdebt term notes and working capital lines of credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Proceeds from borrowing under secured debt facilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Repayments of borrowing under secured debt facilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Repayments of borrowings under unsecured and subdebt notes and working capital facility

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

Issuance of common stock for services, option and warrant exercises

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

23

23

22

26

5

0

0

0

-

-

-

-

1

0

0

0

-

-

-

-

GAFI proceeds from borrowings

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

GAFI repayments of borrowings

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from Series A preferred units financing

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from borrowings under unsecured short term notes and working capital lines of credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Repayments of borrowings under unsecured working capital facilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net cash provided by financing activities

9,946

10,085

10,775

7,782

10,968

10,391

6,843

8,165

8,364

8,375

8,250

4,175

2,986

1,627

-3,850

-4,029

-6,430

816

1,530

2,370

-7,725

-23,226

-19,691

-18,108

-5,564

6,250

10,736

34,317

33,767

33,336

28,309

4,658

3,414

1,865

0

0

0

Effect of exchange rate changes on cash and cash equivalents

-17

-5

-17

-28

-56

-51

95

62

111

371

107

207

101

-166

44

-85

-8

-8

-26

11

-2

5

-84

-159

-303

-156

-112

36

169

101

-58

-20

8

-84

0

0

0

Net cash and cash equivalents for period

260

-532

851

-719

-350

760

-1,681

402

162

-1,058

1,097

76

-94

1,203

-1,864

-2,734

-5,184

-49

-2,978

-1,455

-1,809

-4,594

4,381

4,655

7,266

4,635

1,035

22

-59

42

-135

-455

-126

-433

0

0

0

Supplemental disclosures of cash flow information, cash paid:
Cash paid for interest, net of capitalized interest of $88 and $64 for the three months ended March 31, 2020 and 2019, respectively

1,809

2,476

2,726

4,076

4,970

5,590

5,917

5,032

3,429

3,092

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

2,300

1,310

1,215

1,021

0

0

0

Interest payments to related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

Income taxes paid

16

8

0

0

0

6

6

6

6

6

6

6

6

6

6

6

6

6

6

6

6

6

6

6

6

6

6

6

6

4

3

4

4

3

0

0

0

Supplemental disclosures of cash flow information, non-cash transactions:
Subordinated debt extension fees added to debt

680

680

680

680

680

680

680

680

680

680

680

680

680

680

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options applied to accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

21

21

21

21

16

16

16

16

0

0

0

0

-

-

-

-

-

-

-

-

Payment of principal and interest through the issuance of stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Fair value of warrants issued to subordinated debt holders

188

162

162

237

237

235

235

212

212

321

322

425

425

579

578

747

747

1,087

1,087

1,874

1,874

1,301

1,301

95

227

1,127

1,127

210

304

0

0

2,369

2,143

1,452

0

0

0

TEC debt extension, waiver fees, promissory notes fees added to debt

529

1,602

1,102

1,352

1,696

4,255

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Capital expenditures in accounts payable

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities arising from obtaining right-of-use assets

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Capital expenditures purchased on financing

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repurchase of common stock added to TEC promissory note

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

TEC promissory notes fees added to notes

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Transfer between debt and other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

438

438

438

438

0

0

0

0

-

-

-

-

-

-

-

-

Stock issued in connection with services and interest on debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

715

715

506

0

0

0

0

-

-

-

-

-

-

-

-

Repurchase of common stock on agent advance sub debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Senior debt extension and waiver fees added to debt

-

-

-

-

-

-

-

-

-

-

4,446

3,846

3,846

4,940

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of principal, fees and interest paid in stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,616

554

11,717

12,350

11,886

0

0

0

-

-

-

-

Warrant liability transferred to equity upon exercise

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,007

1,007

1,007

1,007

0

0

0

0

-

-

-

-

Settlement of accounts payable through transfer of equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

66

66

66

66

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-